CLINICAL_TRIALS
trial_result
· 2016-03-03
Clinical Trial Update: Bioavailability of Apixaban Crushed Tablet [Phase 1]
Summary
A Phase 1 study evaluated the bioavailability of crushed apixaban tablets in thrombosis, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED | Results posted: 2016-03-03